Cellebrite CMO sells 2,198 shares for RSU taxes
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Cellebrite DI Ltd. (CLBT) reported that Chief Marketing Officer David Nicholas Gee sold 2,198 ordinary shares on August 21, 2026 in an open-market transaction at a weighted average price of $11.2416 per share, with individual trades ranging from $11.16 to $11.30. The shares sold were originally granted as restricted stock units (RSUs) on May 20, 2024, and the disposition is associated with the reporting person’s tax obligations upon vesting of those RSUs. Following this transaction, Gee directly holds 139,604 ordinary shares of Cellebrite DI Ltd.
Insider Trade Summary
Net Seller: 2,198 shares
Net Sell
1 txn
Insider
GEE DAVID NICHOLAS
Role
Chief Marketing Officer
Sold
2,198 shs ($25K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary shares, par value NIS 0.00001 F1, F2 | 2,198 | $11.2416 | $25K |
Holdings After Transaction:
Ordinary shares, par value NIS 0.00001 — 139,604 shares (Direct)
Footnotes (2)
- F1. The shares reported as disposed herein were granted on May 20, 2024, in the form of restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.16 to $11.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Shares sold: 2,198 shares
Weighted average sale price: $11.2416 per share
Sale price range: $11.16 to $11.30 per share
+3 more
6 metrics
Shares sold
2,198 shares
Ordinary shares sold by Chief Marketing Officer on August 21, 2026
Weighted average sale price
$11.2416 per share
Average price for the 2,198 ordinary shares sold
Sale price range
$11.16 to $11.30 per share
Range of prices across multiple sale transactions
Shares owned after transaction
139,604 shares
Direct ordinary share holdings of David Nicholas Gee after the sale
RSU grant date
May 20, 2024
Date the RSUs underlying the disposed shares were granted
Transaction date
August 21, 2026
Date of the open-market sale of ordinary shares
Key Terms
restricted stock units ("RSUs"), weighted average price, vesting
3 terms
restricted stock units ("RSUs") financial
"The shares reported as disposed herein were granted on May 20, 2024, in the form of restricted stock units ("RSUs")."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
vesting financial
"associated with tax obligations of the reporting person associated with the vesting of the RSUs."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did CLBT report for David Nicholas Gee?
Cellebrite DI Ltd. (CLBT) reported that Chief Marketing Officer David Nicholas Gee sold 2,198 ordinary shares on August 21, 2026 in an open-market transaction associated with tax obligations from previously granted RSUs, leaving him with 139,604 shares directly held.
Was the CLBT insider sale made under a Rule 10b5-1 trading plan?
No. The filing’s Rule 10b5-1 checkbox is not marked as affirmative, and there is no footnote stating the sale was made pursuant to a Rule 10b5-1 trading plan. The transaction is instead linked to tax obligations from RSU vesting.
AI-generated analysis. How Rhea-AI works. Not financial advice.
